Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care. (3rd September 2018)

Record Type:: Journal Article
Title:: Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care. (3rd September 2018)
Main Title:: Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care
Authors:: Glintborg, B
Kringelbach, T
Bolstad, N
Warren, DJ
Eng, G
Sørensen, IJ
Loft, AG
Hendricks, O
Hansen, IMJ
Linauskas, A
Nordin, H
Kristensen, S
Lindegaard, H
Jensen, DV
Goll, GL
Høgdall, E
Gehin, J
Enevold, C
Nielsen, CH
Krogh, NS
Johansen, JS
Hetland, ML
Abstract:
Is Part Of:: Scandinavian journal of rheumatology. Volume 47:Number 5(2018)
Journal:: Scandinavian journal of rheumatology
Issue:: Volume 47:Number 5(2018)
Issue Display:: Volume 47, Issue 5 (2018)
Year:: 2018
Volume:: 47
Issue:: 5
Issue Sort Value:: 2018-0047-0005-0000
Page Start:: 418
Page End:: 421
Publication Date:: 2018-09-03
Subjects:: Rheumatology -- Periodicals
Arthritis
Rheumatic Diseases
616.72005
Journal URLs:: http://informahealthcare.com/loi/rhe ↗
http://informahealthcare.com ↗
DOI:: 10.1080/03009742.2017.1376110 ↗
Languages:: English
ISSNs:: 0300-9742
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 8087.546000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 7206.xml